vs
Ispire Technology Inc.（ISPR）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
Ispire Technology Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.5倍（$20.3M vs $13.2M），Ispire Technology Inc.净利率更高（-32.5% vs -73.9%，领先41.3%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs -51.5%），TriSalus Life Sciences, Inc.自由现金流更多（$-2.5M vs $-4.0M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -17.8%）
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
ISPR vs TLSI — 直观对比
营收规模更大
ISPR
是对方的1.5倍
$13.2M
营收增速更快
TLSI
高出111.3%
-51.5%
净利率更高
ISPR
高出41.3%
-73.9%
自由现金流更多
TLSI
多$1.5M
$-4.0M
两年增速更快
TLSI
近两年复合增速
-17.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.3M | $13.2M |
| 净利润 | $-6.6M | $-9.8M |
| 毛利率 | 17.1% | 86.7% |
| 营业利润率 | -33.9% | -24.8% |
| 净利率 | -32.5% | -73.9% |
| 营收同比 | -51.5% | 59.8% |
| 净利润同比 | 17.4% | 3.5% |
| 每股收益（稀释后） | $-0.12 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPRTLSI
| Q4 25 | $20.3M | $13.2M | ||
| Q3 25 | $30.4M | $11.6M | ||
| Q2 25 | $20.1M | $11.2M | ||
| Q1 25 | $26.2M | $9.2M | ||
| Q4 24 | $41.8M | $8.3M | ||
| Q3 24 | $39.3M | $7.3M | ||
| Q2 24 | $37.3M | $7.4M | ||
| Q1 24 | $30.0M | $6.5M |
净利润ISPRTLSI
| Q4 25 | $-6.6M | $-9.8M | ||
| Q3 25 | $-3.3M | $-10.8M | ||
| Q2 25 | $-14.8M | $-8.3M | ||
| Q1 25 | $-10.9M | $-10.4M | ||
| Q4 24 | $-8.0M | $-10.1M | ||
| Q3 24 | $-5.6M | $-2.4M | ||
| Q2 24 | $-3.5M | $-4.3M | ||
| Q1 24 | $-5.9M | $-13.2M |
毛利率ISPRTLSI
| Q4 25 | 17.1% | 86.7% | ||
| Q3 25 | 17.0% | 83.5% | ||
| Q2 25 | 12.3% | 83.9% | ||
| Q1 25 | 18.2% | 83.7% | ||
| Q4 24 | 18.5% | 85.3% | ||
| Q3 24 | 19.5% | 86.3% | ||
| Q2 24 | 28.3% | 87.6% | ||
| Q1 24 | 20.4% | 85.0% |
营业利润率ISPRTLSI
| Q4 25 | -33.9% | -24.8% | ||
| Q3 25 | -8.9% | -77.9% | ||
| Q2 25 | -72.7% | -65.4% | ||
| Q1 25 | -40.4% | -79.9% | ||
| Q4 24 | -17.6% | -91.8% | ||
| Q3 24 | -13.4% | -118.9% | ||
| Q2 24 | -9.2% | -111.0% | ||
| Q1 24 | -18.8% | -180.8% |
净利率ISPRTLSI
| Q4 25 | -32.5% | -73.9% | ||
| Q3 25 | -10.7% | -93.5% | ||
| Q2 25 | -73.4% | -73.9% | ||
| Q1 25 | -41.5% | -113.2% | ||
| Q4 24 | -19.1% | -122.4% | ||
| Q3 24 | -14.2% | -32.6% | ||
| Q2 24 | -9.4% | -58.8% | ||
| Q1 24 | -19.7% | -204.5% |
每股收益（稀释后）ISPRTLSI
| Q4 25 | $-0.12 | $-0.22 | ||
| Q3 25 | $-0.06 | $-0.96 | ||
| Q2 25 | $-0.26 | $-0.27 | ||
| Q1 25 | $-0.19 | $-0.39 | ||
| Q4 24 | $-0.14 | $-0.38 | ||
| Q3 24 | $-0.10 | $-0.12 | ||
| Q2 24 | $-0.07 | $-0.21 | ||
| Q1 24 | $-0.11 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.6M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-7.7M | $-33.9M |
| 总资产 | $84.4M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISPRTLSI
| Q4 25 | $17.6M | $20.4M | ||
| Q3 25 | $22.7M | $22.7M | ||
| Q2 25 | $24.4M | $26.5M | ||
| Q1 25 | $23.5M | $13.0M | ||
| Q4 24 | $34.4M | $8.5M | ||
| Q3 24 | $37.7M | $11.3M | ||
| Q2 24 | $35.1M | $16.5M | ||
| Q1 24 | $39.5M | $4.0M |
股东权益ISPRTLSI
| Q4 25 | $-7.7M | $-33.9M | ||
| Q3 25 | $-1.8M | $-26.7M | ||
| Q2 25 | $604.7K | $-19.4M | ||
| Q1 25 | $14.8M | $-34.4M | ||
| Q4 24 | $24.2M | $-25.9M | ||
| Q3 24 | $30.7M | $-20.4M | ||
| Q2 24 | $34.5M | $-25.3M | ||
| Q1 24 | $35.9M | $-36.0M |
总资产ISPRTLSI
| Q4 25 | $84.4M | $35.3M | ||
| Q3 25 | $96.4M | $36.5M | ||
| Q2 25 | $102.2M | $41.3M | ||
| Q1 25 | $115.7M | $28.6M | ||
| Q4 24 | $132.0M | $24.0M | ||
| Q3 24 | $129.0M | $27.5M | ||
| Q2 24 | $122.6M | $32.4M | ||
| Q1 24 | $108.0M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-2.5M |
| 自由现金流率自由现金流/营收 | -19.9% | -19.1% |
| 资本支出强度资本支出/营收 | 0.3% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.2M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流ISPRTLSI
| Q4 25 | $-4.0M | $-2.5M | ||
| Q3 25 | $-1.2M | $-3.7M | ||
| Q2 25 | $4.7M | $-7.3M | ||
| Q1 25 | $-12.5M | $-4.5M | ||
| Q4 24 | $-3.2M | $-5.7M | ||
| Q3 24 | $3.6M | $-10.8M | ||
| Q2 24 | $-1.4M | $-13.4M | ||
| Q1 24 | $3.4M | $-10.9M |
自由现金流ISPRTLSI
| Q4 25 | $-4.0M | $-2.5M | ||
| Q3 25 | $-1.2M | $-3.9M | ||
| Q2 25 | $3.7M | $-7.4M | ||
| Q1 25 | $-12.7M | $-5.3M | ||
| Q4 24 | $-3.2M | $-5.8M | ||
| Q3 24 | $3.3M | $-11.0M | ||
| Q2 24 | $-2.2M | $-13.5M | ||
| Q1 24 | $3.3M | $-10.9M |
自由现金流率ISPRTLSI
| Q4 25 | -19.9% | -19.1% | ||
| Q3 25 | -3.9% | -33.9% | ||
| Q2 25 | 18.6% | -66.1% | ||
| Q1 25 | -48.4% | -57.3% | ||
| Q4 24 | -7.7% | -69.7% | ||
| Q3 24 | 8.5% | -149.9% | ||
| Q2 24 | -5.9% | -183.1% | ||
| Q1 24 | 10.9% | -169.3% |
资本支出强度ISPRTLSI
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 4.8% | 0.8% | ||
| Q1 25 | 0.7% | 8.2% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.7% | 2.3% | ||
| Q2 24 | 2.0% | 0.8% | ||
| Q1 24 | 0.3% | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
